Eczematous reactions due to angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers

被引:22
|
作者
Vena, Gino A. [1 ]
Cassano, Nicoletta [1 ]
Coco, Valeria [2 ]
De Simone, Clara [2 ]
机构
[1] Univ Bari, Dept Biomed Sci & Human Oncol, Unit Dermatol & Venereol, I-70124 Bari, Italy
[2] Univ Cattolica Sacro Cuore, Unit Dermatol, I-00168 Rome, Italy
关键词
Antihypertensive drugs; cutaneous adverse drug reactions; drug-induced dermatitis; eczema; hydrochlorothiazide; CAPTOPRIL; DRUG; SURVEILLANCE; BRADYKININ; IRBESARTAN; ERUPTION;
D O I
10.3109/08923973.2013.797992
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cutaneous adverse drug reactions (ADRs) to antihypertensive drugs have been frequently reported. We describe a peculiar clinical pattern of cutaneous ADR, represented by an eczematous reaction induced by certain antihypertensive drugs that we observed in elderly patients. The case series consisted of 23 hypertensive patients aged 66-87 years; 19 of them were taking another drug in addition to the suspected antihypertensive medication and 15 were on polytherapy with three or more drugs to treat multiple comorbidities. The antihypertensive culprit agents were angiotensin-converting enzyme (ACE) inhibitors in 9 patients, ACE-inhibitors combined to hydrochlorothiazide (HCT) in 7 subjects, angiotensin II receptor blockers alone in 2 patients and associated with HCT in 5 cases. The cutaneous ADR was characterized by an eczematous rash that was generalized in 16 patients and localized in 7 cases, with predominant involvement of lower limbs. Such lesions developed after a latency of 4-30 months and were associated with moderate-to-severe itch, usually unresponsive to oral antihistamines. Histopathological diagnosis was available for 9 cases, confirming the presence of a spongiotic dermatitis with possible associated psoriasiform skin changes.
引用
收藏
页码:447 / 450
页数:4
相关论文
共 50 条
  • [31] ANGIOTENSIN-CONVERTING ENZYME INHIBITORS VERSUS ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTS WITH HYPERTENSION
    Sanchez, Andres M. Cordova
    Shmorgon, Gary
    Olonoff, Danielle A.
    Ramm, Matthew
    Gualan, Carlos Merino
    Chaudhuri, Debanik
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2074 - 2074
  • [32] Hyperkalemia Associated with Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
    Raebel, Marsha A.
    CARDIOVASCULAR THERAPEUTICS, 2012, 30 (03) : e156 - e166
  • [33] Angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, and risk of appendicitis
    Mukamal, Kenneth J.
    Ghimire, Sanjay
    Pandey, Rudra
    Fiarman, Gale S.
    Gautam, Shiva
    ANNALS OF EPIDEMIOLOGY, 2012, 22 (10) : 747 - 750
  • [34] Melanoma incidence and exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers
    Koomen, E. R.
    Herings, R. M. C.
    Guchelaar, H. J.
    Nijsten, T.
    CANCER EPIDEMIOLOGY, 2009, 33 (05) : 391 - 395
  • [35] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high vascular risk
    Potier, Louis
    Roussel, Ronan
    Elbez, Yedid
    Marre, Michel
    Zeymer, Uwe
    Reid, Christopher M.
    Ohman, Magnus
    Eagle, Kim A.
    Bhatt, Deepak L.
    Steg, Philippe Gabriel
    HEART, 2017, 103 (17) : 1339 - 1346
  • [36] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension due to primary aldosteronism: A case for exclusion
    Bubbar, Carolyn D.
    Blackburn, David F.
    Wilson, Merne P.
    Wilson, Thomas W.
    ANNALS OF PHARMACOTHERAPY, 2007, 41 (01) : 129 - 132
  • [37] Angiotensin converting enzyme inhibitors and angiotensin receptor blockers
    Shrimpton, A. J.
    Walker, S. L. M.
    Ackland, G. L.
    BJA EDUCATION, 2020, 20 (11) : 362 - 367
  • [38] Pharmacogenetics of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARB) in cardiovascular diseases
    Agostini, Livia da Cunha
    Silva, Nayara Nascimento Toledo
    Belo, Vanessa de Almeida
    Luizon, Marcelo Rizzatti
    Lima, Angelica Alves
    da Silva, Glenda Nicioli
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 981
  • [39] Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with chronic kidney disease
    Kolesnyk, I.
    Struijk, D. G.
    Dekker, F. W.
    Krediet, R. T.
    NETHERLANDS JOURNAL OF MEDICINE, 2010, 68 (01): : 15 - 23
  • [40] Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on prevention of stroke: Which one is better?
    Xiao, Lin
    Ouyang, Haichun
    Su, Qiwen
    Huang, Yuli
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 223 : 56 - 57